Predicting Neoadjuvant Chemotherapy Response in Triple-Negative Breast Cancer Using Pre-Treatment Histopathologic Images

• URL: http://arxiv.org/abs/2505.14730v2
• Date: Sat, 26 Jul 2025 02:07:24 GMT
• Title: Predicting Neoadjuvant Chemotherapy Response in Triple-Negative Breast Cancer Using Pre-Treatment Histopathologic Images
• Authors: Hikmat Khan, Ziyu Su, Huina Zhang, Yihong Wang, Bohan Ning, Shi Wei, Hua Guo, Zaibo Li, Muhammad Khalid Khan Niazi,
• Abstract summary: Triple-negative breast cancer (TNBC) remains a major clinical challenge due to its aggressive behavior and lack of targeted therapies.<n>We present an attention-based multiple instance learning framework designed to predict pathologic complete response (pCR) directly from pre-treatment hematoxylin and eosin (H&E)-stained biopsy slides.
• Score: 2.23127246021293
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Triple-negative breast cancer (TNBC) remains a major clinical challenge due to its aggressive behavior and lack of targeted therapies. Accurate early prediction of response to neoadjuvant chemotherapy (NACT) is essential for guiding personalized treatment strategies and improving patient outcomes. In this study, we present an attention-based multiple instance learning (MIL) framework designed to predict pathologic complete response (pCR) directly from pre-treatment hematoxylin and eosin (H&E)-stained biopsy slides. The model was trained on a retrospective in-house cohort of 174 TNBC patients and externally validated on an independent cohort (n = 30). It achieved a mean area under the curve (AUC) of 0.85 during five-fold cross-validation and 0.78 on external testing, demonstrating robust predictive performance and generalizability. To enhance model interpretability, attention maps were spatially co-registered with multiplex immuno-histochemistry (mIHC) data stained for PD-L1, CD8+ T cells, and CD163+ macrophages. The attention regions exhibited moderate spatial overlap with immune-enriched areas, with mean Intersection over Union (IoU) scores of 0.47 for PD-L1, 0.45 for CD8+ T cells, and 0.46 for CD163+ macrophages. The presence of these biomarkers in high-attention regions supports their biological relevance to NACT response in TNBC. This not only improves model interpretability but may also inform future efforts to identify clinically actionable histological biomarkers directly from H&E-stained biopsy slides, further supporting the utility of this approach for accurate NACT response prediction and advancing precision oncology in TNBC.

Related papers

• Predicting Targeted Therapy Resistance in Non-Small Cell Lung Cancer Using Multimodal Machine Learning [0.5116003548817487]
  Lung cancer is the primary cause of cancer death globally, with non-small cell lung cancer (NSCLC) emerging as its most prevalent subtype.<n>Osimertinib, a third-generation EGFR-tyrosine kinase inhibitor (TKI), has demonstrated remarkable efficacy in the treatment of NSCLC patients.<n>Despite its established efficacy, drug resistance poses a significant challenge for patients to fully benefit from osimertinib.
  arXiv  Detail & Related papers  (2025-03-31T14:47:02Z)
• CRTRE: Causal Rule Generation with Target Trial Emulation Framework [47.2836994469923]
  We introduce a novel method called causal rule generation with target trial emulation framework (CRTRE) CRTRE applies randomize trial design principles to estimate the causal effect of association rules. We then incorporate such association rules for the downstream applications such as prediction of disease onsets.
  arXiv  Detail & Related papers  (2024-11-10T02:40:06Z)
• TopoTxR: A topology-guided deep convolutional network for breast parenchyma learning on DCE-MRIs [49.69047720285225]
  We propose a novel topological approach that explicitly extracts multi-scale topological structures to better approximate breast parenchymal structures. We empirically validate emphTopoTxR using the VICTRE phantom breast dataset. Our qualitative and quantitative analyses suggest differential topological behavior of breast tissue in treatment-na"ive imaging.
  arXiv  Detail & Related papers  (2024-11-05T19:35:10Z)
• Benchmarking Histopathology Foundation Models for Ovarian Cancer Bevacizumab Treatment Response Prediction from Whole Slide Images [1.4999444543328293]
  We leverage the latest histopathology foundation models trained on large-scale whole slide image (WSI) to extract ovarian tumor tissue features for predicting bevacizumab response. Our survival models are able to stratify high- and low-risk cases with statistical significance.
  arXiv  Detail & Related papers  (2024-07-30T07:15:39Z)
• Histopathology Based AI Model Predicts Anti-Angiogenic Therapy Response in Renal Cancer Clinical Trial [0.6087644423424302]
  We present a novel deep learning (DL) approach to predict the Angioscore from ubiquitous histopathology slides. Our model produces a visual vascular network which is the basis of the model's prediction. Our approach offers insights into angiogenesis biology and AA treatment response.
  arXiv  Detail & Related papers  (2024-05-28T16:21:20Z)
• Using Multiparametric MRI with Optimized Synthetic Correlated Diffusion Imaging to Enhance Breast Cancer Pathologic Complete Response Prediction [71.91773485443125]
  Neoadjuvant chemotherapy has recently gained popularity as a promising treatment strategy for breast cancer. The current process to recommend neoadjuvant chemotherapy relies on the subjective evaluation of medical experts. This research investigates the application of optimized CDI$s$ to enhance breast cancer pathologic complete response prediction.
  arXiv  Detail & Related papers  (2024-05-13T15:40:56Z)
• Using Pre-training and Interaction Modeling for ancestry-specific disease prediction in UK Biobank [69.90493129893112]
  Recent genome-wide association studies (GWAS) have uncovered the genetic basis of complex traits, but show an under-representation of non-European descent individuals. Here, we assess whether we can improve disease prediction across diverse ancestries using multiomic data.
  arXiv  Detail & Related papers  (2024-04-26T16:39:50Z)
• Developing a Novel Image Marker to Predict the Clinical Outcome of Neoadjuvant Chemotherapy (NACT) for Ovarian Cancer Patients [1.7623658472574557]
  Neoadjuvant chemotherapy (NACT) is one kind of treatment for advanced stage ovarian cancer patients. Partial responses to NACT may lead to suboptimal debulking surgery, which will result in adverse prognosis. We developed a novel image marker to achieve high accuracy prognosis prediction of NACT at an early stage.
  arXiv  Detail & Related papers  (2023-09-13T16:59:50Z)
• Recurrence-Free Survival Prediction for Anal Squamous Cell Carcinoma Chemoradiotherapy using Planning CT-based Radiomics Model [5.485361086613949]
  Approximately 30% of non-metastatic anal squamous cell carcinoma (A SCC) patients will experience recurrence after chemotherapy (CRT) We developed a model leveraging information extracted from radiation pretreatment planning CT to predict recurrence-free survival (RFS) in A SCC patients after CRT.
  arXiv  Detail & Related papers  (2023-09-05T20:22:26Z)
• hist2RNA: An efficient deep learning architecture to predict gene expression from breast cancer histopathology images [11.822321981275232]
  Deep learning algorithms can effectively extract morphological patterns in digital histopathology images to predict molecular phenotypes quickly and cost-effectively. We propose a new, computationally efficient approach called hist2RNA inspired by bulk RNA-sequencing techniques to predict the expression of 138 genes.
  arXiv  Detail & Related papers  (2023-04-10T10:54:32Z)
• Enhancing Clinical Support for Breast Cancer with Deep Learning Models using Synthetic Correlated Diffusion Imaging [66.63200823918429]
  We investigate enhancing clinical support for breast cancer with deep learning models. We leverage a volumetric convolutional neural network to learn deep radiomic features from a pre-treatment cohort. We find that the proposed approach can achieve better performance for both grade and post-treatment response prediction.
  arXiv  Detail & Related papers  (2022-11-10T03:02:12Z)
• Exploiting segmentation labels and representation learning to forecast therapy response of PDAC patients [60.78505216352878]
  We propose a hybrid deep neural network pipeline to predict tumour response to initial chemotherapy. We leverage a combination of representation transfer from segmentation to classification, as well as localisation and representation learning. Our approach yields a remarkably data-efficient method able to predict treatment response with a ROC-AUC of 63.7% using only 477 datasets in total.
  arXiv  Detail & Related papers  (2022-11-08T11:50:31Z)
• Comparison of Machine Learning Classifiers to Predict Patient Survival and Genetics of GBM: Towards a Standardized Model for Clinical Implementation [44.02622933605018]
  Radiomic models have been shown to outperform clinical data for outcome prediction in glioblastoma (GBM) We aimed to compare nine machine learning classifiers to predict overall survival (OS), isocitrate dehydrogenase (IDH) mutation, O-6-methylguanine-DNA-methyltransferase (MGMT) promoter methylation, epidermal growth factor receptor (EGFR) VII amplification and Ki-67 expression in GBM patients. xGB obtained maximum accuracy for OS (74.5%), AB for IDH mutation (88%), MGMT methylation (71,7%), Ki-67 expression (86,6%), and EGFR amplification (81,
  arXiv  Detail & Related papers  (2021-02-10T15:10:37Z)
• MIA-Prognosis: A Deep Learning Framework to Predict Therapy Response [58.0291320452122]
  This paper aims at a unified deep learning approach to predict patient prognosis and therapy response. We formalize the prognosis modeling as a multi-modal asynchronous time series classification task. Our predictive model could further stratify low-risk and high-risk patients in terms of long-term survival.
  arXiv  Detail & Related papers  (2020-10-08T15:30:17Z)
• Deep learning-based prediction of response to HER2-targeted neoadjuvant chemotherapy from pre-treatment dynamic breast MRI: A multi-institutional validation study [0.5149010213385097]
  Predicting response to neoadjuvant therapy is a vexing challenge in breast cancer. Deep learning could provide an effective and reliable tool to guide targeted therapy in breast cancer.
  arXiv  Detail & Related papers  (2020-01-22T17:54:24Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.